Safety, Tolerability, and Preliminary Activity of LB-100,...

  • Main
  • 2016 / 12
  • Safety, Tolerability, and Preliminary Activity of LB-100,...

Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial

Chung, Vincent, Mansfield, Aaron S., Braiteh, Fadi, Richards, Donald, Durivage, Henry, Ungerleider, Richard S., Johnson, Francis, Kovach, John S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-16-2299
Date:
December, 2016
File:
PDF, 4.65 MB
english, 2016
Conversion to is in progress
Conversion to is failed